{"disease":{"id":"haploidentical-allogeneic-hematopoietic-stem-cell-transplantation","name":"haploidentical allogeneic hematopoietic stem cell transplantation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05126849","title":"Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":31,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}